TRIB · Trinity Biotech PLC · Financials
Market Cap
$6.51M
Shares
813,132
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$43.79M
-28.9%
FY2025
Net Income
-$31.79M
-32.4%
FY2024
Gross Margin
38.57%
+3.7pp
FY2025
Operating Margin
-36.06%
-1.7pp
FY2025
Operating Cash Flow
-$5.93M
-41.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $43.79M | $61.56M | $56.83M | $62.52M | $81.15M | $101.98M | $90.44M | $97.04M | $99.14M | $99.61M | $100.2M | |
| $26.9M | $40.11M | $37.38M | $45.25M | $47.7M | $53.4M | $52.32M | $55.59M | $57.25M | $56.13M | $53.68M | |
| $16.89M | $21.44M | $19.45M | $17.27M | $33.45M | $48.58M | $38.12M | $41.45M | $41.89M | $43.48M | $46.51M | |
| 38.57% | 34.83% | 34.22% | 27.62% | 41.23% | 47.64% | 42.15% | 42.72% | 42.25% | 43.65% | 46.42% | |
| $3.63M | $4.54M | $4.38M | $4.14M | $4.5M | $5.08M | $5.33M | $5.37M | $5.66M | $5.04M | $5.07M | |
| $249K | $204K | $0 | $0 | $38M | $40K | $4000 | $79K | $528K | $414K | $68K | |
| -$15.79M | -$21.17M | -$27.05M | -$19.35M | $3.94M | $82K | -$24.11M | -$20.23M | -$37.67M | -$39.85M | $13.51M | |
| -36.06% | -34.38% | -47.59% | -30.95% | 4.85% | 0.08% | -26.66% | -20.85% | -37.99% | -40% | 13.48% | |
| -$15.54M | -$20.96M | -$27.05M | -$19.35M | $41.94M | $122K | -$24.11M | -$20.15M | -$37.14M | -$39.43M | $13.57M | |
| $21.39M | $9.57M | $11.05M | $24.73M | $7.09M | $6.75M | $6.58M | $5.08M | $5.41M | $5.44M | $4.05M | |
| -$37.18M | -$30.73M | -$36.93M | -$43.78M | -$1.92M | -$6.63M | -$30M | -$23.18M | -$39.88M | -$42.14M | $22.94M | |
| $199K | $486K | -$59K | -$194K | -$74K | -$620K | -$1.01M | -$525K | -$1.21M | -$3.56M | $756K | |
| — | -$31.79M | -$24.02M | -$41.01M | $875K | -$6.39M | -$28.91M | -$22.09M | -$40.27M | -$100.63M | $21.8M | |
| — | -51.64% | -42.26% | -65.59% | 1.08% | -6.26% | -31.97% | -22.76% | -40.62% | -101.02% | 21.75% |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2018: $17.56M in buybacks, $5.1M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.